The World Health Organization on Saturday said that it is discontinuing the anti malarial drug Hydroxycut, a queen and combination HIV drug Lipan IBD region Rita Navid from the solidarity trial after they failed to reduce the fatality rate among Corbould, 19. The United Nations body called for the action to stop the trials of Hydroxycut Queen and combination drug lopping Ivied the region RBD on hospitalized patients with Corbould, 19. The decision came following the interim results that showed the drugs produce little or no reduction in mortality.

The World Health Organization, in a statement, said that the decision was taken on the recommendation of the Trials International Steering Committee. However, the World Health Organization also clarified that this discontinuation will not affect other studies where these drugs are used for non hospitalized patients as a medicine in pre or post. Corbould 19 treatment. The W8 chores announcement to halt these drugs from solidarity trial came as WHL reported more than two hundred thousand new Corban 19 cases globally on Saturday.

This was the highest single day surge ever recorded in this outbreak. The solidarity trial started out in five parts looking at a possible treatment approaches to Corbould 19. These included standard care or treatment without any specific modifications. In fact, these included treatment without any specific medications, not remedies. Indeed, the antiviral drug, the antimalarial drug, hydroxyl, little queen and combination trials on HIV drugs, Lupino be written off.